Division of Neurosurgery, Geneva University Hospitals and University of Geneva, Geneva, Switzerland.
Nat Methods. 2010 Mar;7(3):224-8. doi: 10.1038/nmeth.1430. Epub 2010 Feb 21.
Tumor-initiating cells with stem cell properties are believed to sustain the growth of gliomas, but proposed markers such as CD133 cannot be used to identify these cells with sufficient specificity. We report an alternative isolation method purely based on phenotypic qualities of glioma-initiating cells (GICs), avoiding the use of molecular markers. We exploited intrinsic autofluorescence properties and a distinctive morphology to isolate a subpopulation of cells (FL1(+)) from human glioma or glioma cultures. FL1(+) cells are capable of self-renewal in vitro, tumorigenesis in vivo and preferentially express stem cell genes. The FL1(+) phenotype did not correlate with the expression of proposed GIC markers. Our data propose an alternative approach to investigate tumor-initiating potential in gliomas and to advance the development of new therapies and diagnostics.
肿瘤起始细胞具有干细胞特性,被认为能维持神经胶质瘤的生长,但目前提出的 CD133 等标记物不能足够特异性地识别这些细胞。我们报告了一种基于神经胶质瘤起始细胞(GIC)表型特性的替代分离方法,避免使用分子标记物。我们利用固有自发荧光特性和独特的形态学,从人神经胶质瘤或神经胶质瘤培养物中分离出一个细胞亚群(FL1(+))。FL1(+)细胞具有体外自我更新、体内致瘤性,并优先表达干细胞基因。FL1(+)表型与提出的 GIC 标记物的表达无关。我们的数据提出了一种新的方法来研究神经胶质瘤中的肿瘤起始潜能,并推进新疗法和诊断方法的开发。